Generally, individuals with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol, may qualify for Semaglutide GLP-1 treatment

Many studies show that berberine can significantly lower blood sugar levels in people with type 2 diabetes ( decrease insulin resistance, making the blood sugar-lowering hormone insulin more effective increase glycolysis, helping your body break down sugars inside cells decrease sugar production in your liver slow the breakdown of carbohydrates in your gut increase the number of beneficial bacteria in your gut In a 2008 study of 116 people with diabetes, taking 1 gram of berberine per day lowered fasting blood sugar by 20% ( It also lowered hemoglobin A1c (HbA1c), a marker of long-term blood sugar regulation, by 12% and improved levels of blood lipids such as cholesterol and triglycerides ( According to an older review of 14 studies, berberine may be as effective as certain oral diabetes drugs, including metformin, glipizide, and rosiglitazone ( It works very well in combination with lifestyle changes and has additive effects when used with other blood sugar-lowering drugs ( Summary Berberine has been shown to help lower blood sugar and HbA1c

Coverage Considerations The medical association notes that generic availability will likely prompt provincial drug plans and private insurers to reassess coverage policies
Oral vs Injectable GLP-1: Complete Format Comparison for 2026 With Wegovy Pill and Foundayo now available, patients can choose between daily pills and weekly injections
Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT
doi: 10.1530/ERC-19-0510 130 RossKCAndrewsAJMarionCDYenTJBhattacharjeeV